Browsing by Subject "Observaciones de primera dosis"

Now showing items 1-1 of 1

Safety and tolerability of Fingolimod in Latin american patients with relapsing-remitting multiple sclerosis: the open-label FIRST LATAM study.

Ordoñez-Boschetti, Laura; Rey, Roberto; Cruz, Ana; Sinha, Arijit; Reynolds, Tracy; Frider, Nadina; Alvarenga, Regina (Springer Naure, 2015-07)
Acceso abierto

Introduction: Fingolimod 0.5 mg is an orally active sphingosine 1-phosphate receptor modulator approved for use in adults with relapsing multiple sclerosis (MS). The efficacy and safety profile of fingolimod has been well ...